Ubenimex

Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bestatin and Ubenimexum. Its PubChem CID is 72172.

CAS No 58970-76-6
Molecular Formula C16H24N2O4
Molecular Weight 308.37 g/mol
Synonyms (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid

Frequently Asked Questions